Skip to main content

Find Clinical Trials

Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Not Yet Recruiting

CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma

NCT06913179

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma

NCT06913192

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Proteomic Analysis of Patients Undergoing Bariatric Surgery

NCT06787807

Conditions: Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +95 more
Locations: Hospital das clínicas da UFPE Recife, Pernambuco, Brazil

View Trial Details

Not Yet Recruiting

SIL as Maintenance Therapy in Multiple Myeloma

NCT06744894

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma

NCT06742138

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma

NCT06705725

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma

NCT06594211

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Bleeding in Multiple Myeloma

NCT06482931

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant

NCT05982275

Conditions: Allogeneic Stem Cell Transplantation, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain

Hospital Santa Creu i Sant Pau Barcelona, Spain

Complejo asistencial universitario de Salamanca Salamanca, Spain

José Antonio Pérez Simón Seville, Spain

View Trial Details

Not Yet Recruiting

Study of SYS6020 in BCMA-positive Multiple Myeloma

NCT06359509

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details